U.S. flag

An official website of the United States government

GTR Home > Tests > OnkoSight Advanced Breast Cancer Panel

Overview

Test order codeHelp: TP57

Test name

Help

OnkoSight Advanced Breast Cancer Panel

Purpose of the test

Help

This is a clinical test intended for Help: Diagnosis, Drug Response, Predictive, Prognostic, Therapeutic management

Condition

Help

Loading data ......

Click Indication tab for more information.

How to order

Help

Order URL Help: https://www.genpathdiagnostics.com/

Methodology

Help
Molecular Genetics
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Other

Summary of what is tested

Loading data ......

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

Not provided

Suggested reading

Clinical resources

Practice guidelines

  • NICE, 2024
    UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2024
  • NICE, 2023
    UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023
  • NCCN, 2023
    NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast Cancer, 2023
  • NCCN, 2023
    Breast Cancer, NCCN Guidelines Version 4.2022
  • NICE, 2018
    Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.